| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14740338.3.3.221 |
| P698 | PubMed publication ID | 15155150 |
| P50 | author | Michael Berk | Q30504747 |
| P2093 | author name string | Seetal Dodd | |
| P2860 | cites work | Intellectual problems shown by 11-year-old children whose mothers had postnatal depression | Q28203729 |
| Nephrogenic diabetes insipidus in transplacental lithium intoxication | Q28325679 | ||
| Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding | Q28332667 | ||
| Atrial flutter in the newborn resulting from maternal lithium ingestion | Q28367533 | ||
| Lithium toxicity in a neonate | Q28367536 | ||
| Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero | Q28378312 | ||
| Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid | Q33499660 | ||
| Antidepressants and breast-feeding: a review of the literature | Q33999207 | ||
| Verification of the fetal valproate syndrome phenotype | Q34166934 | ||
| The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation | Q34349772 | ||
| Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study | Q34518006 | ||
| Maternal depression: a child's first adverse life event | Q34601675 | ||
| Case report and review of the perinatal implications of maternal lithium use. | Q34736308 | ||
| Clinical pharmacokinetics of oxcarbazepine | Q35213465 | ||
| Effects of postnatal depression on infant development | Q35256353 | ||
| Antiepileptic drug pharmacokinetics during pregnancy and lactation | Q35540892 | ||
| Recent developments in the treatment of bipolar disorders | Q35547289 | ||
| Assessment and treatment of depression during pregnancy: an update | Q35561511 | ||
| Spina bifida in infants of women treated with carbamazepine during pregnancy | Q37639771 | ||
| Letter: Transplacental lithium poisoning: Reversible inhibition of fetal thyroid | Q39329369 | ||
| A reevaluation of risk of in utero exposure to lithium | Q40671619 | ||
| The fetal valproate syndrome | Q42249396 | ||
| Spina bifida and in-utero exposure to valproate | Q42591453 | ||
| Maternal valproic acid and congenital neural tube defects | Q42591925 | ||
| Epidemiology of puerperal psychoses | Q43509819 | ||
| Pattern of malformations in the children of women treated with carbamazepine during pregnancy | Q43779596 | ||
| Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate | Q43896010 | ||
| Transplacental passage of oxcarbazepine and its metabolites in vivo | Q43906050 | ||
| Quetiapine and pregnancy | Q43941607 | ||
| Olanzapine versus divalproex in the treatment of acute mania | Q44013092 | ||
| Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 | ||
| Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants | Q44538144 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Olanzapine-exposed pregnancies and lactation: early experience | Q47665193 | ||
| Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study | Q47869465 | ||
| Puerperal mental disorders in manic-depressive females. | Q52131870 | ||
| Protective effect of pregnancy in women with lithium-responsive bipolar disorder. | Q53330534 | ||
| Effects of Maternal Depression on Cognitive Development of Children Over the First 7 Years of Life | Q56637142 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| breastfeeding | Q174876 | ||
| P304 | page(s) | 221-229 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | The pharmacology of bipolar disorder during pregnancy and breastfeeding | |
| P478 | volume | 3 |
| Q35311467 | A consensus statement for safety monitoring guidelines of treatments for major depressive disorder |
| Q34765790 | Anesthetic care for electroconvulsive therapy during pregnancy -A case report-. |
| Q56039529 | Bipolar disorder |
| Q93075688 | Childbirth and prevention of bipolar disorder: an opportunity for change |
| Q51834824 | Clinical characteristics and management of bipolar disorder in women across the life span. |
| Q37279424 | Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses |
| Q36476778 | Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers |
Search more.